Changgeng Qian
Corporate Officer/Principal chez Central South University
Profil
Changgeng Qian is a professor at Central South University since 1992.
Prior to this, he worked as Head-Pharmacology at CytoMed, Inc. from 1992 to 1995, Senior Research Scientist at LeukoSite, Inc. from 1996 to 1999, and Senior Scientist at Millennium Pharmaceuticals, Inc. from 1999 to 2001.
From 2010 to 2012, he worked as Senior VP-Discovery & Preclinical Development at Curis, Inc. Dr. Qian holds a doctorate degree from Central South University.
Postes actifs de Changgeng Qian
| Sociétés | Poste | Début |
|---|---|---|
| Central South University | Corporate Officer/Principal | 01/01/1992 |
Anciens postes connus de Changgeng Qian
| Sociétés | Poste | Fin |
|---|---|---|
| CURIS, INC. | Directeur Technique/Scientifique/R&D | 16/02/2012 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/05/2001 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/11/1999 |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Corporate Officer/Principal | 01/12/1995 |
Formation de Changgeng Qian
| Central South University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
CytoMed, Inc.
CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Health Technology |
